Cargando…
Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
BACKGROUND: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study w...
Autores principales: | Qiu, Yan, Lin, Jing, Yang, Yang, Zhou, Jing, Gong, Li-Na, Qin, Zhen, Du, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794879/ https://www.ncbi.nlm.nih.gov/pubmed/26612285 http://dx.doi.org/10.4103/0366-6999.170364 |
Ejemplares similares
-
Effects of Ulinastatin on Postoperative Blood Loss and Hemostasis in Atrioventricular Valve Surgery with Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2013) -
Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan
por: Zhang, Yun, et al.
Publicado: (2014) -
Effect of high-dose ulinastatin on the cardiopulmonary bypass-induced inflammatory response in patients undergoing open-heart surgery
por: Liu, Yu, et al.
Publicado: (2020) -
Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
por: Wang, Xiaocou, et al.
Publicado: (2015) -
Ulinastatin to prevent acute kidney injury after cardiopulmonary bypass surgery: does serum creatinine tell the whole story?
por: Honore, Patrick M., et al.
Publicado: (2016)